Metabolic diseases such as T2D, insulin resistance, and adipose tissue dysfunction course with low systemic PRL levels [18, 19, 20, 21, 22, 23], whereas PRL administration improves insulin sensitivity and decreases adipocyte hypertrophy in HFD-induced obese male rats [13]. This evidence concerns the gene INS and metabolic disease.